11th annual ADMET conference and exhibition

The SMi Group is proud to announce the return of the 11th annual ADMET conference taking place in London on the 13th – 14th June. 

This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.

ADMET 2016 will provide a series of practical case studies, interactive roundtables and panel discussions facilitated by leading industry experts that will provide executives with useful tools and best practices to: 

• Discover application of PBPK to drug development in rare diseases 
• Review the role of drug transporters in drug delivery to CNS diseases 
• Learn about better models for understanding, predicting and avoiding drug induced liver injury 
• Discuss in silico approaches to evidence-based mechanistic modelling 
• Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules

2016 Speaker Line up:

CHAIRMAN:
• Nick Plant, Reader in Systems Biology, University of Surrey

KEYNOTE SPEAKERS:
•    Thierry Lave, Head DMPK and TOX Project Leaders and Modeling & Simulation, Roche Pharmaceuticals
•    Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
•    Kunal Taskar, Senior Investigator, DMPK, GSK
•    Karelle Menochet, Principal Scientist DMPK, UCB Pharma
•    Laurent Salphati, Senior Scientist, Genentech
•    Carl Petersson, DMPK NCE Senior Designer, Merck Serono
•    Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck